Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Energy BioSystems, Maxygen enabling technology news

By WIR Staff | May 1, 2000 | 7:00 AM GMT

MAXY is seeking an arbitration

Read the full 56 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE